Home ›
Breast Cancer Trials ›
NCT04843865
TCM as an Adjuvant Treatment in Breast Cancer Patients
Chinese herbs can alleviates the side effects caused by conventional treatment in breast cancer patients and affects the syndrome element differentiation by altering the specific set of proteomes at specific time point of treatment.
Trial Details
NCT ID NCT04843865
Phase NA
Sponsor Universiti Tunku Abdul Rahman
Status RECRUITING
Cancer Type Breast Cancer
Interventions
Locations (sample) Bukit Bintang, Kuala Lumpur, Malaysia|3.14657,101.71023
Key Eligibility Criteria
Postmenopausal women as determined by cessation of menses for at least 1 year or FSH\>20 mIU/mL Histology confirmed stage 2 to 3 hormone-receptor positive breast cancer patient Currently taking letrozole for at least 1 month Reported ongoing musculoskeletal pain or stiffness, which started or worsened after initiation of letrozole
For full eligibility, visit ClinicalTrials.gov .
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Breast Cancer Trials on Trialify →